Conflict of Interest: None
Headache Following Intracranial Neuroendovascular Procedures
Article first published online: 28 DEC 2011
© 2011 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 52, Issue 5, pages 739–748, May 2012
How to Cite
Baron, E. P., Moskowitz, S. I., Tepper, S. J., Gupta, R., Novak, E., Hussain, M. S. and Stillman, M. J. (2012), Headache Following Intracranial Neuroendovascular Procedures. Headache: The Journal of Head and Face Pain, 52: 739–748. doi: 10.1111/j.1526-4610.2011.02059.x
- Issue published online: 4 MAY 2012
- Article first published online: 28 DEC 2011
- Accepted for publication October 10, 2010.
- aneurysm embolization;
Aims.— Predicting who will develop post-procedure headache (PPH) following intracranial endovascular procedures (IEPs) would be clinically useful and potentially could assist in reducing the excessive diagnostic testing so often obtained in these patients. Although limited safety data exist, the use of triptans or dihydroergotamine (DHE) often raise concern when used with pre/post-coiled aneurysms. We sought to determine risk factors for PPH following IEP, to evaluate the utility of diagnostic testing in patients with post-coil acute headache (HA), and to record whether triptans and DHE have been used safely in this clinical setting.
Methods.— We conducted a retrospective chart review of adult patients undergoing IEPs. Bivariate analyses were conducted to compare patients who did and did not develop PPH.
Results.— We reviewed records pertaining to 372 patients, of whom 263 underwent intracranial coil embolizations, 21 acrylic glue embolizations, and 88 stent placements. PPH occurred in 72% of coil patients, 33% of glue patients, and 14% of stent patients. Significant risk factors for post-coil HA were female gender, any pre-coil HA history, smoking, and anxiety/depression. A pre-stent history of HA exceeding 1 year's duration, and smoking were risk factors for post-stent HA. A pre-glue history of HA exceeding 1 year was the only risk factor for post-glue HA. In the small subgroup available for study, treatment with triptans or DHE was not associated with adverse events in pre/post-coiled aneurysms. Diagnostic testing was low yield.
Conclusions.— Occurrence of PPH was common after IEPs and especially so with coiling and in women, smokers, and those with anxiety/depression, and was often of longer duration than allowed by current International Classification of Headache Disorders-II criteria. The yield of diagnostic testing was low, and in a small subgroup treatment with triptans or DHE did not cause adverse events in pre/post-coiled aneurysms. Prospective studies are needed to confirm these findings.